| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | NEK10 CAMK4 STK17A RPS6KA1 STK32B MINK1 RIPK2 CDKL3 DAPK1 STK32C MAP3K6 TTK CDKL5 AURKC PHKG1 MAPK14 PDIK1L PRKAA2 DCLK2 IKBKB PRKX PLK3 PRKY | 5.87e-13 | 363 | 188 | 23 | GO:0106310 |
| GeneOntologyMolecularFunction | protein kinase activity | FLT4 NEK10 CAMK4 STK17A RPS6KA1 NTRK2 NTRK3 STK32B MINK1 RIPK2 CDKL3 BAZ1B DAPK1 STK32C MAP3K6 TTK CDKL5 AURKC PHKG1 MAPK14 PDIK1L PRKAA2 DCLK2 IKBKB PRKX PLK3 PRKY | 1.58e-11 | 600 | 188 | 27 | GO:0004672 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | NEK10 CAMK4 STK17A RPS6KA1 STK32B MINK1 RIPK2 CDKL3 DAPK1 STK32C MAP3K6 TTK CDKL5 AURKC PHKG1 MAPK14 PDIK1L PRKAA2 DCLK2 IKBKB PRKX PLK3 PRKY | 3.92e-11 | 446 | 188 | 23 | GO:0004674 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | FLT4 NEK10 CAMK4 STK17A RPS6KA1 NTRK2 NTRK3 STK32B MINK1 RIPK2 CDKL3 BAZ1B DAPK1 STK32C MAP3K6 TTK CDKL5 AURKC PHKG1 GK MAPK14 PDIK1L PRKAA2 DCLK2 IKBKB PRKX PLK3 PRKY | 1.33e-10 | 709 | 188 | 28 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | FLT4 NEK10 CAMK4 STK17A RPS6KA1 NTRK2 NTRK3 STK32B MINK1 RIPK2 CDKL3 BAZ1B DAPK1 STK32C TRRAP MAP3K6 TTK CDKL5 AURKC PHKG1 GK MAPK14 PDIK1L PRKAA2 DCLK2 IKBKB PRKX PLK3 PRKY | 1.53e-10 | 764 | 188 | 29 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | FLT4 NEK10 CAMK4 STK17A RPS6KA1 NTRK2 NTRK3 STK32B MINK1 RIPK2 CDKL3 BAZ1B PAPOLB DAPK1 STK32C SIRT6 TRRAP MAP3K6 TTK CDKL5 AURKC PHKG1 GK MAPK14 PDIK1L PRKAA2 PARP9 DCLK2 IKBKB PRKX PLK3 PRKY | 2.30e-10 | 938 | 188 | 32 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 7.81e-05 | 47 | 188 | 5 | GO:0004712 | |
| GeneOntologyMolecularFunction | methylcrotonoyl-CoA carboxylase activity | 8.82e-05 | 2 | 188 | 2 | GO:0004485 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.94e-04 | 37 | 188 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | NAD transmembrane transporter activity | 8.65e-04 | 5 | 188 | 2 | GO:0051724 | |
| GeneOntologyMolecularFunction | TORC2 complex binding | 8.65e-04 | 5 | 188 | 2 | GO:1904841 | |
| GeneOntologyMolecularFunction | neurotrophin receptor activity | 8.65e-04 | 5 | 188 | 2 | GO:0005030 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 8.67e-04 | 210 | 188 | 8 | GO:0019903 | |
| GeneOntologyMolecularFunction | phosphatase binding | 9.19e-04 | 264 | 188 | 9 | GO:0019902 | |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 1.29e-03 | 6 | 188 | 2 | GO:0016421 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | ERCC6 CAMK4 RPS6KA1 NTRK2 NTRK3 STK32B RIPK2 STK32C TTK MAPK14 DCLK2 IKBKB PRKX | 4.84e-06 | 307 | 187 | 13 | GO:0018105 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | ERCC6 CAMK4 RPS6KA1 NTRK2 NTRK3 STK32B RIPK2 STK32C TTK MAPK14 DCLK2 IKBKB PRKX | 7.32e-06 | 319 | 187 | 13 | GO:0018209 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | SPRY1 RPGRIP1L TSC2 KRIT1 PARD6B TTC8 KANK1 DST PLEKHG3 MACF1 NCKAP1L | 2.39e-05 | 257 | 187 | 11 | GO:0007163 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 4.59e-05 | 228 | 187 | 10 | GO:0046777 | |
| GeneOntologyCellularComponent | glutamatergic synapse | GABRR1 ATG16L1 MYO5B ADAM23 CAMK4 NTRK2 NTRK3 ITGA8 DAPK1 TSC2 SRCIN1 GRM3 SYT10 ADD2 GRIP1 CDKL5 MAPK14 NGEF BSN CDH11 | 3.95e-05 | 817 | 185 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | methylcrotonoyl-CoA carboxylase complex | 7.79e-05 | 2 | 185 | 2 | GO:1905202 | |
| GeneOntologyCellularComponent | postsynaptic density | NTRK2 MINK1 ITGA8 DAPK1 TSC2 SRCIN1 GRM3 ADD2 GRIP1 CDKL5 DST MACF1 BSN | 1.99e-04 | 451 | 185 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | dendrite | DAB2IP MYO5B CYP11B1 NTRK2 MINK1 ITGA8 TSC2 SRCIN1 GRM3 PDLIM4 GRIP1 CDKL5 IFT52 PTPRK KCNJ12 PRKAA2 KCNJ18 BSN PLK3 | 2.28e-04 | 858 | 185 | 19 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DAB2IP MYO5B CYP11B1 NTRK2 MINK1 ITGA8 TSC2 SRCIN1 GRM3 PDLIM4 GRIP1 CDKL5 IFT52 PTPRK KCNJ12 PRKAA2 KCNJ18 BSN PLK3 | 2.34e-04 | 860 | 185 | 19 | GO:0097447 |
| GeneOntologyCellularComponent | asymmetric synapse | NTRK2 MINK1 ITGA8 DAPK1 TSC2 SRCIN1 GRM3 ADD2 GRIP1 CDKL5 DST MACF1 BSN | 3.42e-04 | 477 | 185 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | NTRK2 MINK1 ITGA8 DAPK1 TSC2 SRCIN1 GRM3 ADD2 GRIP1 CDKL5 DST MACF1 BSN | 5.63e-04 | 503 | 185 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | neuron to neuron synapse | NTRK2 MINK1 ITGA8 DAPK1 TSC2 SRCIN1 GRM3 ADD2 GRIP1 CDKL5 DST MACF1 BSN | 8.07e-04 | 523 | 185 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | protein kinase complex | 8.12e-04 | 170 | 185 | 7 | GO:1902911 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | NEK10 DAPK1 RB1CC1 MYZAP TRRAP PARD6B PHKG1 PRKAA2 TAF7 IKBKB | 8.34e-04 | 335 | 185 | 10 | GO:0061695 |
| Domain | Kinase-like_dom | FLT4 NEK10 CAMK4 STK17A RPS6KA1 NTRK2 NTRK3 STK32B MINK1 RIPK2 CDKL3 DAPK1 STK32C TRRAP MAP3K6 TTK CDKL5 AURKC PHKG1 MAPK14 DST PDIK1L PRKAA2 MACF1 DCLK2 IKBKB PRKX PLK3 PRKY | 1.00e-13 | 542 | 184 | 29 | IPR011009 |
| Domain | PROTEIN_KINASE_ATP | FLT4 NEK10 CAMK4 STK17A RPS6KA1 NTRK2 NTRK3 STK32B MINK1 RIPK2 CDKL3 DAPK1 STK32C MAP3K6 TTK CDKL5 AURKC PHKG1 MAPK14 PDIK1L PRKAA2 DCLK2 IKBKB PRKX PLK3 PRKY | 5.86e-13 | 459 | 184 | 26 | PS00107 |
| Domain | S_TKc | NEK10 CAMK4 STK17A RPS6KA1 STK32B MINK1 RIPK2 CDKL3 DAPK1 STK32C MAP3K6 TTK CDKL5 AURKC PHKG1 MAPK14 PDIK1L PRKAA2 DCLK2 IKBKB PRKX PLK3 PRKY | 1.14e-12 | 359 | 184 | 23 | SM00220 |
| Domain | Prot_kinase_dom | FLT4 NEK10 CAMK4 STK17A RPS6KA1 NTRK2 NTRK3 STK32B MINK1 RIPK2 CDKL3 DAPK1 STK32C MAP3K6 TTK CDKL5 AURKC PHKG1 MAPK14 PDIK1L PRKAA2 DCLK2 IKBKB PRKX PLK3 PRKY | 2.48e-12 | 489 | 184 | 26 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | FLT4 NEK10 CAMK4 STK17A RPS6KA1 NTRK2 NTRK3 STK32B MINK1 RIPK2 CDKL3 DAPK1 STK32C MAP3K6 TTK CDKL5 AURKC PHKG1 MAPK14 PDIK1L PRKAA2 DCLK2 IKBKB PRKX PLK3 PRKY | 2.98e-12 | 493 | 184 | 26 | PS50011 |
| Domain | Protein_kinase_ATP_BS | FLT4 NEK10 CAMK4 STK17A RPS6KA1 NTRK2 NTRK3 STK32B MINK1 CDKL3 DAPK1 STK32C MAP3K6 TTK CDKL5 AURKC PHKG1 MAPK14 PDIK1L PRKAA2 DCLK2 PRKX PLK3 | 3.48e-12 | 379 | 184 | 23 | IPR017441 |
| Domain | Pkinase | NEK10 CAMK4 STK17A RPS6KA1 STK32B MINK1 RIPK2 CDKL3 DAPK1 STK32C MAP3K6 TTK CDKL5 AURKC PHKG1 MAPK14 PDIK1L PRKAA2 DCLK2 IKBKB PRKX PLK3 PRKY | 3.88e-12 | 381 | 184 | 23 | PF00069 |
| Domain | Ser/Thr_kinase_AS | CAMK4 STK17A RPS6KA1 STK32B MINK1 RIPK2 CDKL3 DAPK1 STK32C MAP3K6 TTK CDKL5 AURKC PHKG1 MAPK14 PDIK1L PRKAA2 DCLK2 IKBKB PRKX PLK3 PRKY | 7.86e-12 | 357 | 184 | 22 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | CAMK4 STK17A RPS6KA1 STK32B MINK1 RIPK2 CDKL3 DAPK1 STK32C MAP3K6 TTK CDKL5 AURKC PHKG1 MAPK14 PDIK1L PRKAA2 DCLK2 IKBKB PRKX PLK3 PRKY | 1.03e-11 | 362 | 184 | 22 | PS00108 |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 5.18e-06 | 69 | 184 | 7 | IPR020636 | |
| Domain | zf-C2H2 | ZNF555 ZNF484 ZNF658 ZNF268 ZNF423 ZSCAN26 ZNF233 ZNF302 PRDM5 PRDM4 ZNF501 ZFPM2 ZNF587B ZNF461 ZNF250 ZNF630 ZNF713 ZNF37A ZSCAN30 ZNF30 | 1.73e-05 | 693 | 184 | 20 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF555 ZNF484 ZNF658 ZNF268 ZNF423 ZSCAN26 ZNF233 ZNF302 PRDM5 PRDM4 ZNF501 ZFPM2 ZNF587B ZNF461 ZNF250 ZNF630 ZNF713 ZNF37A ZSCAN30 ZNF30 | 1.76e-05 | 694 | 184 | 20 | IPR013087 |
| Domain | Znf_C2H2-like | ZNF555 ZNF484 ZNF658 ZNF268 ZNF423 MATR3 ZSCAN26 ZNF233 ZNF302 PRDM5 PRDM4 ZNF501 ZFPM2 ZNF587B ZNF461 ZNF250 ZNF630 ZNF713 ZNF37A ZSCAN30 ZNF30 | 3.96e-05 | 796 | 184 | 21 | IPR015880 |
| Domain | - | ZNF555 ZNF484 ZNF658 ZNF268 ZNF423 ZSCAN26 ZNF233 ZNF302 PRDM5 PRDM4 ZNF501 ZFPM2 ZNF587B ZNF461 ZNF250 ZNF630 ZNF37A ZSCAN30 ZNF30 | 4.31e-05 | 679 | 184 | 19 | 3.30.160.60 |
| Domain | ZnF_C2H2 | ZNF555 ZNF484 ZNF658 ZNF268 ZNF423 MATR3 ZSCAN26 ZNF233 ZNF302 PRDM5 PRDM4 ZNF501 ZFPM2 ZNF587B ZNF461 ZNF250 ZNF630 ZNF713 ZNF37A ZSCAN30 ZNF30 | 4.91e-05 | 808 | 184 | 21 | SM00355 |
| Domain | KRAB | ZNF555 ZNF484 ZNF658 ZNF268 ZNF233 ZNF302 ZNF587B ZNF461 ZNF250 ZNF630 ZNF713 ZNF37A ZNF30 | 5.75e-05 | 358 | 184 | 13 | PS50805 |
| Domain | KRAB | ZNF555 ZNF484 ZNF658 ZNF268 ZNF233 ZNF302 ZNF587B ZNF461 ZNF250 ZNF630 ZNF713 ZNF37A ZNF30 | 5.75e-05 | 358 | 184 | 13 | PF01352 |
| Domain | KRAB | ZNF555 ZNF484 ZNF658 ZNF268 ZNF233 ZNF302 ZNF587B ZNF461 ZNF250 ZNF630 ZNF713 ZNF37A ZNF30 | 7.81e-05 | 369 | 184 | 13 | SM00349 |
| Domain | KRAB | ZNF555 ZNF484 ZNF658 ZNF268 ZNF233 ZNF302 ZNF587B ZNF461 ZNF250 ZNF630 ZNF713 ZNF37A ZNF30 | 8.02e-05 | 370 | 184 | 13 | IPR001909 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF555 ZNF484 ZNF658 ZNF268 ZNF423 ZSCAN26 ZNF233 ZNF302 PRDM5 PRDM4 ZNF501 ZFPM2 ZNF587B ZNF461 ZNF250 ZNF630 ZNF713 ZNF37A ZSCAN30 ZNF30 | 8.26e-05 | 775 | 184 | 20 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF555 ZNF484 ZNF658 ZNF268 ZNF423 ZSCAN26 ZNF233 ZNF302 PRDM5 PRDM4 ZNF501 ZFPM2 ZNF587B ZNF461 ZNF250 ZNF630 ZNF713 ZNF37A ZSCAN30 ZNF30 | 8.55e-05 | 777 | 184 | 20 | PS00028 |
| Domain | K_chnl_inward-rec_Kir2.2 | 9.65e-05 | 2 | 184 | 2 | IPR003272 | |
| Domain | Znf_C2H2 | ZNF555 ZNF484 ZNF658 ZNF268 ZNF423 ZSCAN26 ZNF233 ZNF302 PRDM5 PRDM4 ZNF501 ZFPM2 ZNF587B ZNF461 ZNF250 ZNF630 ZNF713 ZNF37A ZSCAN30 ZNF30 | 1.38e-04 | 805 | 184 | 20 | IPR007087 |
| Domain | K_chnl_inward-rec_Kir_N | 2.88e-04 | 3 | 184 | 2 | IPR013673 | |
| Domain | IRK_N | 2.88e-04 | 3 | 184 | 2 | PF08466 | |
| Domain | TPKR_C2 | 2.88e-04 | 3 | 184 | 2 | PF16920 | |
| Domain | Tyr_kinase_NGF_rcpt | 2.88e-04 | 3 | 184 | 2 | IPR020777 | |
| Domain | NTRK_C2 | 2.88e-04 | 3 | 184 | 2 | IPR031635 | |
| Domain | ROC_dom | 5.72e-04 | 4 | 184 | 2 | IPR020859 | |
| Domain | ROC | 5.72e-04 | 4 | 184 | 2 | PS51424 | |
| Domain | Pep_M12B_propep | 5.73e-04 | 39 | 184 | 4 | PF01562 | |
| Domain | Peptidase_M12B_N | 5.73e-04 | 39 | 184 | 4 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 6.32e-04 | 40 | 184 | 4 | PS00427 | |
| Domain | Reprolysin | 6.32e-04 | 40 | 184 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 6.32e-04 | 40 | 184 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 6.32e-04 | 40 | 184 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 6.32e-04 | 40 | 184 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 6.94e-04 | 41 | 184 | 4 | IPR001762 | |
| Domain | PLAC | 8.11e-04 | 19 | 184 | 3 | PS50900 | |
| Domain | PLAC | 8.11e-04 | 19 | 184 | 3 | IPR010909 | |
| Domain | VWA_N | 9.47e-04 | 5 | 184 | 2 | IPR013608 | |
| Domain | VWA_N | 9.47e-04 | 5 | 184 | 2 | PF08399 | |
| Domain | zf-C2H2_6 | ZNF555 ZNF658 ZNF423 ZNF302 PRDM5 ZNF501 ZNF461 ZNF250 ZSCAN30 ZNF30 | 1.14e-03 | 314 | 184 | 10 | PF13912 |
| Domain | - | 1.41e-03 | 6 | 184 | 2 | 3.90.1290.10 | |
| Domain | GAR | 1.41e-03 | 6 | 184 | 2 | PS51460 | |
| Domain | GAS2 | 1.41e-03 | 6 | 184 | 2 | PF02187 | |
| Domain | - | 1.41e-03 | 6 | 184 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.41e-03 | 6 | 184 | 2 | IPR003108 | |
| Domain | GAS2 | 1.41e-03 | 6 | 184 | 2 | SM00243 | |
| Domain | LRR_8 | 1.55e-03 | 171 | 184 | 7 | PF13855 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.63e-03 | 24 | 184 | 3 | IPR013273 | |
| Domain | Plectin | 1.96e-03 | 7 | 184 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.96e-03 | 7 | 184 | 2 | IPR001101 | |
| Domain | PLEC | 1.96e-03 | 7 | 184 | 2 | SM00250 | |
| Domain | Bromodomain_CS | 2.07e-03 | 26 | 184 | 3 | IPR018359 | |
| Domain | ADAM_Cys-rich | 2.31e-03 | 27 | 184 | 3 | IPR006586 | |
| Domain | ACR | 2.31e-03 | 27 | 184 | 3 | SM00608 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.48e-03 | 138 | 184 | 6 | IPR001245 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | CAMK4 RPS6KA1 NTRK2 NTRK3 TSC2 GRIP1 CDKL5 MAPK14 PRKAA2 IKBKB | 1.57e-06 | 144 | 139 | 10 | M39691 |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 3.45e-05 | 126 | 139 | 8 | M16763 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | FLT4 CAMK4 RPS6KA1 NTRK2 NTRK3 STK32B MINK1 STK32C MAP3K6 AURKC NPRL2 ASB6 PDIK1L PRKAA2 DCLK2 PRKX PRKY | 3.00e-11 | 372 | 190 | 17 | 22939624 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MCMBP INPPL1 NTRK3 MATR3 MINK1 RIPK2 TSC2 STK32C MCCC1 MAP3K6 TTK GRIP1 DST PLEKHG3 PRKAA2 MACF1 DCLK2 USP6NL DOP1B | 3.01e-07 | 861 | 190 | 19 | 36931259 |
| Pubmed | AKAP6 FLII DMXL2 COPB1 ADAM23 ZNF423 ADAM9 TSC2 CACHD1 ZNF302 ARID1A PRDM4 KRIT1 NPRL2 DST PTPRK NGEF MACF1 DCLK2 RSBN1L SCAI DOP1B BRWD1 | 6.45e-07 | 1285 | 190 | 23 | 35914814 | |
| Pubmed | DAB2IP FLII ARHGAP26 MIB2 MCCC1 TUBGCP2 ADD2 GRIP1 CDKL5 PHKG1 GK MACF1 SCAI | 8.10e-07 | 430 | 190 | 13 | 32581705 | |
| Pubmed | DAB2IP FLII DMXL2 ADAM9 NTRK2 MATR3 MINK1 RIPK2 DAPK1 TSC2 CHD7 GRM3 DST NGEF MACF1 KIF4B BSN MGA CDH11 | 1.59e-06 | 963 | 190 | 19 | 28671696 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | STK17A CCDC186 RPS6KA1 INPPL1 MINK1 RIPK2 MCCC2 RB1CC1 TRRAP MAP3K6 TTK AURKC MAPK14 DST PRKAA2 PSME3 IKBKB SCAI | 2.94e-06 | 910 | 190 | 18 | 36736316 |
| Pubmed | TSC2 RB1CC1 ARID1A BIRC6 TULP2 FANCD2 PARD6B BORCS8 MAPK14 ASB6 MGA | 5.11e-06 | 359 | 190 | 11 | 35559673 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 5.58e-06 | 231 | 190 | 9 | 16452087 | |
| Pubmed | FLII DMXL2 COPB1 MYO5B ARHGAP26 MATR3 MINK1 DAPK1 SRCIN1 ARID1A GRM3 ADD2 CDKL5 DST LRIG1 NGEF MACF1 DCLK2 MCAT BSN CACNA2D3 SCAI | 1.29e-05 | 1431 | 190 | 22 | 37142655 | |
| Pubmed | FLII MCMBP COPB1 CMC1 MATR3 BAZ1B BTAF1 MCCC2 SIRT6 SHOC2 DDX54 MCAT PSME3 BSN | 1.60e-05 | 653 | 190 | 14 | 33742100 | |
| Pubmed | DAB2IP FLII DMXL2 CAMK4 NTRK2 MINK1 MIB2 SRCIN1 MCCC2 MCCC1 SHOC2 BIRC6 SLC25A51 RYR2 CDKL5 MACF1 SLC25A52 DCLK2 BSN | 1.73e-05 | 1139 | 190 | 19 | 36417873 | |
| Pubmed | 2.56e-05 | 11 | 190 | 3 | 23785138 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 7633447 | ||
| Pubmed | Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. | 2.97e-05 | 2 | 190 | 2 | 15289440 | |
| Pubmed | Abnormal development of pacinian corpuscles in double trkB;trkC knockout mice. | 2.97e-05 | 2 | 190 | 2 | 17101216 | |
| Pubmed | NLRP3 inflammasome activation triggers gasdermin D-independent inflammation. | 2.97e-05 | 2 | 190 | 2 | 34678046 | |
| Pubmed | IKKβ primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network. | 2.97e-05 | 2 | 190 | 2 | 36384135 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 15757502 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 27601257 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 9195161 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 11002341 | ||
| Pubmed | Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2. | 2.97e-05 | 2 | 190 | 2 | 38309262 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 21562748 | ||
| Pubmed | Estrogen receptor is involved in the osteoarthritis mediated by Atg16L1-NLRP3 activation. | 2.97e-05 | 2 | 190 | 2 | 39189559 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 11401427 | ||
| Pubmed | Man to mouse--lessons learned from the distal end of the human X chromosome. | 2.97e-05 | 2 | 190 | 2 | 9414316 | |
| Pubmed | Profiles of PrKX expression in developmental mouse embryo and human tissues. | 2.97e-05 | 2 | 190 | 2 | 15879576 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 30455347 | ||
| Pubmed | Mutational spectrum in eight Korean patients with 3-methylcrotonyl-CoA carboxylase deficiency. | 2.97e-05 | 2 | 190 | 2 | 22150417 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 23776632 | ||
| Pubmed | The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling. | 2.97e-05 | 2 | 190 | 2 | 16213824 | |
| Pubmed | The role of RIP2 in p38 MAPK activation in the stressed heart. | 2.97e-05 | 2 | 190 | 2 | 18310079 | |
| Pubmed | Gasdermin-D activation promotes NLRP3 activation and host resistance to Leishmania infection. | 2.97e-05 | 2 | 190 | 2 | 36828815 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 16010683 | ||
| Pubmed | TrkB but not trkC receptors are necessary for postnatal maintenance of hippocampal spines. | 2.97e-05 | 2 | 190 | 2 | 17442456 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 29392887 | ||
| Pubmed | Role of Kir2.2 in hypercapnic ventilatory response during postnatal development of mouse. | 2.97e-05 | 2 | 190 | 2 | 15705530 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 35403694 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 19839650 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 21684272 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 35536742 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 9302280 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 14622193 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 32906142 | ||
| Pubmed | TIMELESS mutation alters phase responsiveness and causes advanced sleep phase. | 2.97e-05 | 2 | 190 | 2 | 31138685 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 12885297 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 11406611 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 28228349 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 37777961 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 9421165 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 37800794 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 18974095 | ||
| Pubmed | The combined effects of trkB and trkC mutations on the innervation of the inner ear. | 2.97e-05 | 2 | 190 | 2 | 9881298 | |
| Pubmed | Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms. | 2.97e-05 | 2 | 190 | 2 | 32315394 | |
| Pubmed | Expression, purification, characterization of human 3-methylcrotonyl-CoA carboxylase (MCCC). | 2.97e-05 | 2 | 190 | 2 | 17360195 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 15726425 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 22264772 | ||
| Pubmed | Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation. | 2.97e-05 | 2 | 190 | 2 | 32366830 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 31989218 | ||
| Pubmed | Novel mutations in five Japanese patients with 3-methylcrotonyl-CoA carboxylase deficiency. | 2.97e-05 | 2 | 190 | 2 | 17968484 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 17765884 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 28386063 | ||
| Pubmed | The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency. | 2.97e-05 | 2 | 190 | 2 | 11181649 | |
| Pubmed | Mutagenesis as an unbiased approach to identify novel contraceptive targets. | 2.97e-05 | 2 | 190 | 2 | 16412559 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 34360710 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 28629999 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 23332094 | ||
| Pubmed | Novel mutations in the human MCCA and MCCB gene causing methylcrotonylglycinuria. | 2.97e-05 | 2 | 190 | 2 | 21071250 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 25382614 | ||
| Pubmed | Conditional deletion of TrkC does not modify limbic epileptogenesis. | 2.97e-05 | 2 | 190 | 2 | 22980123 | |
| Pubmed | The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolism. | 2.97e-05 | 2 | 190 | 2 | 11170888 | |
| Pubmed | Distinct requirements for TrkB and TrkC signaling in target innervation by sensory neurons. | 2.97e-05 | 2 | 190 | 2 | 11877382 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 18293376 | ||
| Pubmed | Sirt6 deacetylase activity regulates circadian rhythms via Per2. | 2.97e-05 | 2 | 190 | 2 | 30782483 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 7588071 | ||
| Pubmed | [Genetic analysis of newborns with abnormal metabolism of 3-hydroxyisovalerylcarnitine]. | 2.97e-05 | 2 | 190 | 2 | 31901042 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 11352932 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 21895414 | ||
| Pubmed | TrkB-mediated protection against circadian sensitivity to noise trauma in the murine cochlea. | 2.97e-05 | 2 | 190 | 2 | 24583017 | |
| Pubmed | A novel murine PKA-related protein kinase involved in neuronal differentiation. | 2.97e-05 | 2 | 190 | 2 | 10729225 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 33871879 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 22869039 | ||
| Pubmed | 3.59e-05 | 225 | 190 | 8 | 12168954 | ||
| Pubmed | DAB2IP ZNF484 ZNF658 ZNF658B KIF24 SLC25A51 B4GALT1 KANK1 CCDC180 SCAI | 4.02e-05 | 370 | 190 | 10 | 15164053 | |
| Pubmed | PITRM1 INPPL1 MATR3 CENPO TSC2 PRDM4 TRRAP BIRC6 TTK FANCD2 AURKC NPRL2 ZNF37A BTBD7 DDX54 MTO1 MGA RUNDC1 SCAI CAPN15 | 4.31e-05 | 1327 | 190 | 20 | 32694731 | |
| Pubmed | 4.41e-05 | 13 | 190 | 3 | 28561066 | ||
| Pubmed | 4.41e-05 | 13 | 190 | 3 | 10049592 | ||
| Pubmed | 4.73e-05 | 234 | 190 | 8 | 36243803 | ||
| Pubmed | 5.48e-05 | 74 | 190 | 5 | 15276183 | ||
| Pubmed | 7.73e-05 | 251 | 190 | 8 | 29778605 | ||
| Pubmed | Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome". | 8.53e-05 | 16 | 190 | 3 | 29878059 | |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 34930303 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 38297162 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 15647351 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 9232598 | ||
| Pubmed | Gangliosides activate Trk receptors by inducing the release of neurotrophins. | 8.87e-05 | 3 | 190 | 2 | 12388556 | |
| Pubmed | Tumor suppressor death-associated protein kinase is required for full IL-1β production. | 8.87e-05 | 3 | 190 | 2 | 21041719 | |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 33259938 | ||
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 8.87e-05 | 3 | 190 | 2 | 12399109 | |
| Pubmed | F-actin dampens NLRP3 inflammasome activity via Flightless-I and LRRFIP2. | 8.87e-05 | 3 | 190 | 2 | 27431477 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF555 ZNF484 ZNF658 ZNF268 ZNF423 ZSCAN26 ZNF233 ZNF302 PRDM5 PRDM4 ZNF501 ZFPM2 ZNF587B ZNF461 ZNF250 ZNF630 ZNF713 ZNF37A ZSCAN30 ZNF30 | 6.84e-08 | 718 | 122 | 20 | 28 |
| GeneFamily | Ankyrin repeat domain containing|Death associated protein kinases | 4.46e-04 | 5 | 122 | 2 | 1021 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.85e-04 | 161 | 122 | 6 | 593 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.23e-03 | 8 | 122 | 2 | 939 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.47e-03 | 40 | 122 | 3 | 321 | |
| GeneFamily | Non-clustered protocadherins | 2.85e-03 | 12 | 122 | 2 | 21 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | AKAP6 ADAM23 CCDC186 NTRK3 STK32B ITGA8 TSC2 SRCIN1 RB1CC1 GRM3 RYR2 ZFPM2 GRIP1 KIAA1549L NALCN PTPRK PDIK1L PRKAA2 NGEF PCDH11X DCLK2 BSN RUNDC1 SCAI DOP1B BRWD1 | 9.50e-08 | 1106 | 187 | 26 | M39071 |
| Coexpression | GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP | 1.36e-06 | 193 | 187 | 10 | M4961 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 3.02e-06 | 32 | 187 | 5 | MM17 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 4.12e-06 | 34 | 187 | 5 | M45005 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DMXL2 PDE8A BAZ1B DAPK1 BTAF1 RB1CC1 TRAPPC8 SHOC2 TRRAP TTK KRIT1 PCF11 MAPK14 DST LRIG1 PTPRK ATAD2B MACF1 DOP1B | 1.29e-05 | 856 | 187 | 19 | M4500 |
| Coexpression | GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP | 1.39e-05 | 199 | 187 | 9 | M9782 | |
| Coexpression | GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN | 1.44e-05 | 200 | 187 | 9 | M9028 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.75e-05 | 180 | 187 | 8 | M8239 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | NTRK3 ITGA8 DAPK1 ZFPM2 ADAMTS12 DST HMCN1 PTPRK MACF1 CDH11 CA3 | 7.15e-10 | 194 | 188 | 11 | 71d3c7448b1734de54187f902f65649f9283bd4c |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ADAM23 CAMK4 RYR2 ZFPM2 CDKL5 KIAA1549L PTPRK NGEF CACNA2D3 SCAI | 8.85e-09 | 190 | 188 | 10 | d594da827e3c16644952b9589cc12b947ce36279 |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | ITGA8 RYR2 ADAMTS12 DST HMCN1 NALCN MACF1 CDH11 CACNA2D3 CA3 | 1.03e-08 | 193 | 188 | 10 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.86e-08 | 166 | 188 | 9 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.86e-08 | 166 | 188 | 9 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-08 | 179 | 188 | 9 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-08 | 184 | 188 | 9 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-08 | 185 | 188 | 9 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.07e-07 | 187 | 188 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.07e-07 | 187 | 188 | 9 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-07 | 191 | 188 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.34e-07 | 192 | 188 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ADAM23 CAMK4 ARHGAP26 RYR2 ZFPM2 CDKL5 KIAA1549L NGEF CACNA2D3 | 1.34e-07 | 192 | 188 | 9 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.40e-07 | 193 | 188 | 9 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.47e-07 | 194 | 188 | 9 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ADAM23 CAMK4 ARHGAP26 RYR2 CDKL5 KIAA1549L NGEF CACNA2D3 SCAI | 1.53e-07 | 195 | 188 | 9 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-07 | 196 | 188 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-07 | 198 | 188 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.74e-07 | 198 | 188 | 9 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.82e-07 | 199 | 188 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-07 | 199 | 188 | 9 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-07 | 199 | 188 | 9 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-07 | 160 | 188 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-07 | 160 | 188 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.01e-06 | 180 | 188 | 8 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.52e-06 | 190 | 188 | 8 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.52e-06 | 190 | 188 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | T_cells-Effector_memory_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.52e-06 | 190 | 188 | 8 | 1af91fe0ee2c924e12f4db93c793e7af475d8f80 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-06 | 190 | 188 | 8 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.64e-06 | 192 | 188 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-06 | 193 | 188 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.71e-06 | 193 | 188 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 194 | 188 | 8 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 194 | 188 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-06 | 195 | 188 | 8 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-06 | 195 | 188 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-06 | 195 | 188 | 8 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.84e-06 | 195 | 188 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-06 | 196 | 188 | 8 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 196 | 188 | 8 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.92e-06 | 196 | 188 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-06 | 196 | 188 | 8 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-06 | 197 | 188 | 8 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-06 | 197 | 188 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-06 | 197 | 188 | 8 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-06 | 198 | 188 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-06 | 198 | 188 | 8 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-06 | 199 | 188 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-06 | 199 | 188 | 8 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-06 | 199 | 188 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.15e-06 | 199 | 188 | 8 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-06 | 200 | 188 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.23e-06 | 200 | 188 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.23e-06 | 200 | 188 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-06 | 200 | 188 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-06 | 200 | 188 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-06 | 200 | 188 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.23e-06 | 200 | 188 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.87e-06 | 162 | 188 | 7 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.87e-06 | 162 | 188 | 7 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.45e-06 | 168 | 188 | 7 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | Healthy/Control-MAIT|Healthy/Control / Disease group and Cell class | 9.02e-06 | 173 | 188 | 7 | 56247c1e07477a8922fe2e3950ae05e2217fd77c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.02e-06 | 173 | 188 | 7 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.73e-06 | 175 | 188 | 7 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 177 | 188 | 7 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-05 | 177 | 188 | 7 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 178 | 188 | 7 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 178 | 188 | 7 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-05 | 180 | 188 | 7 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-05 | 185 | 188 | 7 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.50e-05 | 187 | 188 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 1.50e-05 | 187 | 188 | 7 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.66e-05 | 190 | 188 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.71e-05 | 191 | 188 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-05 | 191 | 188 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.77e-05 | 192 | 188 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-05 | 192 | 188 | 7 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.83e-05 | 193 | 188 | 7 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-05 | 193 | 188 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.83e-05 | 193 | 188 | 7 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 193 | 188 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.83e-05 | 193 | 188 | 7 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.83e-05 | 193 | 188 | 7 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.83e-05 | 193 | 188 | 7 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.89e-05 | 194 | 188 | 7 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-05 | 194 | 188 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.89e-05 | 194 | 188 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-05 | 194 | 188 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.89e-05 | 194 | 188 | 7 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-05 | 194 | 188 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.89e-05 | 194 | 188 | 7 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.96e-05 | 195 | 188 | 7 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.96e-05 | 195 | 188 | 7 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 196 | 188 | 7 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 196 | 188 | 7 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 196 | 188 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 196 | 188 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-05 | 196 | 188 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 196 | 188 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 197 | 188 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| Disease | Gastric Adenocarcinoma | 7.59e-06 | 45 | 178 | 5 | C0278701 | |
| Disease | Methylcrotonyl-CoA carboxylase deficiency | 3.62e-05 | 2 | 178 | 2 | cv:C4551505 | |
| Disease | 3-methylcrotonyl CoA carboxylase 1 deficiency | 3.62e-05 | 2 | 178 | 2 | C0268600 | |
| Disease | Addicted to cocaine | 1.08e-04 | 3 | 178 | 2 | C0858355 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | AKAP6 FLII ZNF423 NTRK3 MINK1 CHD7 BTAF1 STK32C BIRC6 RYR2 MAPK14 PTPRK CACNA2D3 SCAI BRWD1 | 1.12e-04 | 801 | 178 | 15 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | advanced sleep phase syndrome (is_implicated_in) | 2.15e-04 | 4 | 178 | 2 | DOID:0050628 (is_implicated_in) | |
| Disease | Metastatic melanoma | 3.20e-04 | 54 | 178 | 4 | C0278883 | |
| Disease | Carcinoma of lung | 3.50e-04 | 23 | 178 | 3 | C0684249 | |
| Disease | bilirubin measurement | ATG16L1 FAM114A1 INPP5D CACHD1 ARID1A BIRC6 NLRP3 PHKG1 NGEF STEAP1B | 3.75e-04 | 442 | 178 | 10 | EFO_0004570 |
| Disease | West Syndrome | 3.98e-04 | 24 | 178 | 3 | C0037769 | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 4.21e-04 | 58 | 178 | 4 | DOID:10652 (biomarker_via_orthology) | |
| Disease | cortical surface area measurement | SPRY1 PDE8A COPB1 MFHAS1 ZNF423 DAPK1 CHD7 CACHD1 PRDM5 ADAMTSL3 ELAC2 STN1 GRIP1 NPRL2 LRIG1 ATAD2B MACF1 STEAP1B CDH11 | 5.20e-04 | 1345 | 178 | 19 | EFO_0010736 |
| Disease | Alcohol Related Birth Defect | 5.34e-04 | 6 | 178 | 2 | C3146244 | |
| Disease | central nervous system cancer, glioma | 7.03e-04 | 29 | 178 | 3 | EFO_0000326, EFO_0005543 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 7.77e-04 | 30 | 178 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | Large cell carcinoma of lung | 9.41e-04 | 32 | 178 | 3 | C0345958 | |
| Disease | stomach cancer (is_implicated_in) | 9.57e-04 | 72 | 178 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Schizophrenia | GABRR1 MYO5B NTRK2 NTRK3 ITGA8 RB1CC1 GRM3 ADAMTSL3 TRRAP ADAMTS12 NPRL2 MAPK14 PDIK1L MCAT | 9.82e-04 | 883 | 178 | 14 | C0036341 |
| Disease | lymphatic vessel endothelial hyaluronic acid receptor 1 measurement | 9.89e-04 | 8 | 178 | 2 | EFO_0020539 | |
| Disease | internet addiction disorder | 1.03e-03 | 33 | 178 | 3 | EFO_0803368 | |
| Disease | comparative body size at age 10, self-reported | 1.07e-03 | 420 | 178 | 9 | EFO_0009819 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.62e-03 | 206 | 178 | 6 | C0152013 | |
| Disease | C-reactive protein measurement | AKAP6 DMXL2 MFHAS1 RPS6KA1 BAZ1B MIB2 CHD7 CACHD1 NLRP3 ZFPM2 GSDMD MACF1 RORC PSME3 BSN STEAP1B | 2.71e-03 | 1206 | 178 | 16 | EFO_0004458 |
| Disease | Primary Ciliary Dyskinesia | 2.88e-03 | 47 | 178 | 3 | C4551720 | |
| Disease | eating disorder, bipolar disorder | 3.14e-03 | 14 | 178 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | chronic obstructive pulmonary disease | AKAP6 WDR64 MFHAS1 ITGA8 PELI1 ADAMTSL3 STN1 HMCN1 KCNJ18 DTHD1 CACNA2D3 | 3.19e-03 | 688 | 178 | 11 | EFO_0000341 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.24e-03 | 49 | 178 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | RASopathy | 3.61e-03 | 15 | 178 | 2 | cv:C5555857 | |
| Disease | sitting height ratio | 3.63e-03 | 51 | 178 | 3 | EFO_0007118 | |
| Disease | Leukemia, Myelocytic, Acute | 4.07e-03 | 173 | 178 | 5 | C0023467 | |
| Disease | Tetralogy of Fallot | 4.11e-03 | 16 | 178 | 2 | C0039685 | |
| Disease | T-Cell Lymphoma | 4.11e-03 | 16 | 178 | 2 | C0079772 | |
| Disease | aortic measurement | 4.30e-03 | 251 | 178 | 6 | EFO_0020865 | |
| Disease | Ciliopathies | 4.50e-03 | 110 | 178 | 4 | C4277690 | |
| Disease | attempted suicide | 4.59e-03 | 178 | 178 | 5 | EFO_0004321 | |
| Disease | serine measurement, amino acid measurement | 4.64e-03 | 17 | 178 | 2 | EFO_0005134, EFO_0009774 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 5.20e-03 | 18 | 178 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Age-related macular degeneration | 5.20e-03 | 18 | 178 | 2 | cv:C0242383 | |
| Disease | Disorder of organic acid metabolism | 5.20e-03 | 18 | 178 | 2 | cv:C1263739 | |
| Disease | Lung Neoplasms | 5.58e-03 | 265 | 178 | 6 | C0024121 | |
| Disease | Polydactyly | 5.59e-03 | 117 | 178 | 4 | C0152427 | |
| Disease | Malignant neoplasm of lung | 5.68e-03 | 266 | 178 | 6 | C0242379 | |
| Disease | prion disease | 5.78e-03 | 19 | 178 | 2 | EFO_0004720 | |
| Disease | Cannabis use, age at onset | 5.78e-03 | 19 | 178 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | response to methotrexate, neurotoxicity | 5.78e-03 | 19 | 178 | 2 | EFO_0011057, GO_0031427 | |
| Disease | Alcoholic Intoxication, Chronic | 5.88e-03 | 268 | 178 | 6 | C0001973 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 5.96e-03 | 447 | 178 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 6.01e-03 | 61 | 178 | 3 | DOID:3587 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RHVAELLINHAQAPI | 391 | Q14146 | |
| LLLTQNNDIIPKHHI | 11 | Q13166 | |
| ENQSPVELHTKDIRH | 26 | P07451 | |
| VELHTKDIRHDPSLQ | 31 | P07451 | |
| QAHRVHDDKPNIVLI | 21 | P54793 | |
| TEEIQKPQRVVHHRK | 441 | Q5W0A0 | |
| SILKEIQHPNVITLH | 66 | P53355 | |
| HKVAIIIPFRNRQEH | 176 | P15291 | |
| TEKTRIPTEDLHHNL | 776 | Q8NEM8 | |
| IERLIKHQHELEQRT | 881 | Q7Z3E2 | |
| EIEIQAHLQHPNILR | 91 | Q9UQB9 | |
| ADQHLRHVEKDVLIP | 6 | Q7Z7K0 | |
| LVHDEKSTGRPHIIQ | 236 | O75077 | |
| SIDISQDKLRRHHVP | 3656 | Q9NR09 | |
| LLQRPVTQEIHKHQL | 241 | Q96LI9 | |
| LQAEKHDVPNRHEIS | 56 | Q676U5 | |
| AQLRIKHQEELTELH | 86 | Q676U5 | |
| VHRDLKPENVLLDAH | 136 | P54646 | |
| QDIIHSIHLARKPNL | 1026 | Q9UIG0 | |
| LHSNNIIHRDIKPEN | 116 | Q8IVW4 | |
| ILFQPQKNVVTHRLH | 826 | Q14832 | |
| QTLLHERHLRQPEHK | 131 | P57764 | |
| ERHLRQPEHKVLQQL | 136 | P57764 | |
| TVRPQSKHIVVILDH | 221 | Q5VU97 | |
| HITHKEPLVANDILN | 866 | Q5VU97 | |
| IHLKPVTLLTEQDHV | 121 | Q8WYK0 | |
| VLRNQPDMVELLVHH | 111 | Q9NWX5 | |
| SIIPQDHHEVKRRQS | 206 | Q8TDJ6 | |
| LHLHQPRAQQIEKDI | 916 | Q9P1Z9 | |
| EQVLHHPQLGERLKL | 2066 | Q9P2D1 | |
| ALLHIDRHQIQAVEP | 71 | Q03468 | |
| PVHHDVAVLLTRKDI | 336 | P58397 | |
| HIQIEALEKSPHRIV | 741 | Q8WXS8 | |
| EEKLHRQPVSHRLFQ | 691 | Q8IXQ6 | |
| HILLFNISIPRHEQI | 131 | Q9UK05 | |
| ILAEHLQTLHQKPTE | 181 | Q9NQX1 | |
| ENNLPSLHLITIKAH | 471 | Q9NPG4 | |
| LLQHVHKIPNVDVLV | 46 | Q9BYG5 | |
| HKPDLNHILRLSVEE | 31 | O75808 | |
| AQSHRNIKILEDEPH | 1946 | O14497 | |
| ALLHIDRHQIQAVEP | 71 | P0DP91 | |
| RKELHQLLPHHVLQD | 491 | Q9NRJ5 | |
| EPLHQHVLALHNLVK | 606 | Q8TDY2 | |
| VHPNKDNSRRVEHIL | 201 | Q5VWQ8 | |
| VNNLLLHVEPKRKEH | 1776 | Q14667 | |
| VLNKNHLVTLPEAIH | 346 | Q13045 | |
| KQELGRVIHLSNLPH | 491 | P43243 | |
| SHIVEAHVRAQLIKP | 221 | Q14500 | |
| TERHHLTPDNQLLVV | 736 | Q96JA1 | |
| ALVNQLHERVEHIKL | 51 | Q9HCC0 | |
| HHTQPSEKIRIEIIA | 1141 | Q68CZ1 | |
| LSHHQVEIKQEFPRE | 36 | Q14409 | |
| LHENRIIHRDLKPEN | 136 | O14920 | |
| TLRHKQVIHPGLQEV | 716 | Q8IWI9 | |
| HVIRLLLKPHVQAQQ | 801 | Q9Y4C4 | |
| LHNGQPLRESKIIHV | 336 | Q16288 | |
| HENGIVHRDLKPENL | 156 | Q16566 | |
| IHSADIIHRDLKPSN | 141 | Q16539 | |
| HTNPRVDEIVLKNLH | 286 | Q9Y2Z2 | |
| RQLRELIAEHKPHID | 5981 | Q03001 | |
| QPQTLQHHIIRTEDI | 461 | A6NM62 | |
| NLPDQKARKHILQIH | 571 | Q9ULI0 | |
| HQECKPHTVRILELL | 2196 | Q9Y3R5 | |
| RELLQHQELHVPSGK | 376 | Q8WW38 | |
| LVQRELQELQTIKHH | 2411 | Q9UPA5 | |
| RLHPQVAHKIQELVS | 416 | Q8N187 | |
| VLLHLLHNVVRPQDQ | 326 | Q8TDD1 | |
| LHGLSIVHRDIKPEN | 506 | Q8N568 | |
| HIVHRDIKGDNVLIN | 766 | O95382 | |
| HPSIQELTEQIHRLL | 456 | O15055 | |
| TRVALQAEKLDHHPE | 51 | P61457 | |
| HKEKRIVHRDLTPNN | 646 | Q6ZWH5 | |
| QKPHEGIIHSLVLRN | 461 | Q86V87 | |
| ELHDVLEIHFQKPTR | 246 | P80217 | |
| EQRRTLHTPKLEHLD | 76 | O75564 | |
| LDKHHDIIIIDHRNP | 121 | O60658 | |
| IELKEHPAHERVLQD | 306 | P53618 | |
| TQHLGPVHREKAEII | 71 | P55160 | |
| TNIPPHQKEREEHLR | 751 | Q5T7B8 | |
| EHGHVEIVKLLLAQP | 1276 | Q14678 | |
| RQLRESIAEHKPHID | 1951 | O94854 | |
| VQILLNHPETDRHIT | 371 | O00522 | |
| KEHLILVSQLEQLHR | 301 | Q9BSJ2 | |
| LHHVVLLQADPVVKN | 1161 | Q6ZVL6 | |
| LNSKHHIIQELPLDN | 956 | Q9BZA7 | |
| QKLIEPAHQHEAALR | 81 | O95402 | |
| RPDKHQVIIGDENHL | 656 | P53708 | |
| NSTIPHLVRKRDVHV | 896 | P53708 | |
| ILDEGHILQLKNIHV | 2341 | Q96RW7 | |
| SLQQVDEHSKPPHLR | 606 | O94913 | |
| AVEKLHHLQPSVIEN | 131 | Q8IVS2 | |
| ALERLIEHINPDKVH | 3741 | Q9P2D7 | |
| RREVHEDAHKQVSPI | 46 | P24046 | |
| VIEAHEQLNVKHEPL | 306 | Q9Y366 | |
| AQQLGEVVKLHPHEL | 26 | O14981 | |
| EVVKLHPHELNNLLS | 31 | O14981 | |
| HVLSRPKVIDQEHDV | 436 | Q8IZS8 | |
| QEHVRRSLPELAQHK | 36 | Q96FH0 | |
| DVEKLQQVDSLHPHR | 96 | P15538 | |
| AEIHNRHQEAKVPVA | 461 | P55287 | |
| LSHHQVEIKQEFPRE | 36 | P32189 | |
| EHIIHLERNKDLLPE | 76 | Q13443 | |
| VLSHQKDNPHRIAVL | 511 | Q6ZMT9 | |
| LVLSNKHVAPDHLLQ | 66 | Q9NSI6 | |
| HLHRQKNEPIHLDVV | 1016 | Q9P203 | |
| TDFIPQHHKQLLLSR | 486 | Q96RQ3 | |
| VHVAHDLIQKLSPRT | 101 | Q9BPY3 | |
| IVNIDPHTAELNHLK | 341 | Q2VIQ3 | |
| DLVIQKPLRIHHHSV | 141 | Q9BU64 | |
| AQDIHVHLIPLQRHL | 306 | Q9NYC9 | |
| DQVKLEILPHHQTRL | 326 | Q9Y3R0 | |
| IVHRDIKPENLLISH | 131 | O76039 | |
| PHLERIREKLAENIH | 876 | Q92736 | |
| PVDNHEKRVIQLHLQ | 1616 | Q6ZTR5 | |
| KIHQDTRLTQHVPLL | 1346 | Q9BXW9 | |
| RIHVILAQKLQHINP | 306 | Q9BTE3 | |
| QHVLIHTQERQIKCP | 691 | Q9UKN5 | |
| QLHKVAELILHGQEE | 461 | Q8IWE2 | |
| QIVVEELHPHRTKRE | 631 | Q15262 | |
| HTPTVKHLEALRQEI | 261 | Q96FA3 | |
| HVALQRHQLLPLVAD | 706 | Q96AX9 | |
| LHKLNIVHRDLKPEN | 141 | Q16816 | |
| RDPEAHIKHLLHQRQ | 381 | Q8N4C8 | |
| EKLQHLLDHPRHVEI | 356 | Q96P20 | |
| RVKQLALRQQPHDHV | 391 | Q96C34 | |
| RADVQILHSHVQLPI | 36 | Q8NET4 | |
| DTLEFKQLIHIEHQP | 341 | Q6PCB5 | |
| HVNLKDRLTIELHPD | 36 | Q15545 | |
| SHIVEAHVRAQLIKP | 221 | B7U540 | |
| HRKIHRIIQQDCQKP | 301 | Q9H668 | |
| KPHIQVRLGEHNIEV | 66 | Q8NHM4 | |
| RLILENHHATIPQKA | 391 | A1L390 | |
| TPLERVQTLLQDHKH | 136 | Q9H1U9 | |
| HKNQIIHRDLKPDNI | 156 | Q8N165 | |
| KAQAHRIHIDPEIQD | 96 | P50479 | |
| SIPDVIRRKQEQHVH | 81 | O43930 | |
| ENERIRKILHPSEAH | 301 | Q8N5V2 | |
| FPLEQHLKQIHEEAL | 271 | Q5JRX3 | |
| VSEIHSLVHRLPEKN | 486 | Q9UNA1 | |
| VVLAKPEHENRISHI | 491 | Q92835 | |
| AVLVKPEHENRISHV | 511 | O15357 | |
| ITLDVAHNQLEHLPK | 241 | Q9UQ13 | |
| TPLERVQTLLQNHKH | 136 | Q3SY17 | |
| PDVFQKQAILHLERH | 311 | Q15477 | |
| HPQQLQHVDERKLIQ | 301 | Q8WTW4 | |
| LVIVNLQPTKHDRHA | 236 | Q8N6T7 | |
| FLHTRDVVHLDLKPQ | 176 | Q9UEE5 | |
| HIIHRDVKPDNILLD | 211 | Q86UX6 | |
| LLREVIHPLATSHQQ | 71 | Q6NZ63 | |
| KEKVLEHSHRPIQLR | 2091 | Q13023 | |
| VENLILLEQEKHRPH | 326 | P35612 | |
| LLEQEKHRPHEVGSV | 331 | P35612 | |
| PDTFVQHIKRHNIVL | 526 | Q16620 | |
| KEPILNIHDLTQIHS | 46 | P61289 | |
| LVLHLQQRTHTGEKP | 256 | P17032 | |
| PHQREKILNEIELHR | 101 | Q9H4B4 | |
| QHHQDKPLFDAVIRL | 71 | Q9UNS1 | |
| HQLTIHQRLHVGEKP | 161 | P17039 | |
| LPDHNVAVERQKHLE | 56 | Q92738 | |
| FPDHVDTQHLIKQLR | 521 | Q8TAM2 | |
| QIVDPKHQEHLVLQF | 476 | O00295 | |
| LIQHERIHTGEKPFQ | 466 | P15622 | |
| ELLQQHVRTHTVEKP | 521 | Q8NEP9 | |
| SILIEHQRIHTGEKP | 426 | Q86W11 | |
| SQLIIHERIHTGEKP | 401 | Q14587 | |
| RSHKIQTQLNLIHPD | 381 | Q9BQ52 | |
| ERLQIFQHLHPIVVQ | 481 | P51449 | |
| EKIQRDVSHNHRLVP | 741 | Q9C0H9 | |
| LRVKNIQELIHGAHI | 56 | Q8NDV3 | |
| RVQVAVKHLHIHTPL | 41 | O43353 | |
| ELKILIHIGNHLNVV | 896 | P35916 | |
| VENPHLQKHILELAS | 576 | Q8N9R8 | |
| QEKHERTHEIIPINV | 71 | O43609 | |
| TLTLEIHAHQEPRKR | 431 | Q6ZUG5 | |
| SIPDVIRLKQEQHVH | 81 | P51817 | |
| HLIKHARVQRQITEP | 151 | Q6XYQ8 | |
| SQLIIHQRIHTGEKP | 276 | Q2M218 | |
| AALIVHQRIHTGEKP | 811 | Q5TYW1 | |
| IILPKELQARVQEHH | 101 | Q16670 | |
| KHILSQHQRLLPREE | 226 | E7ETH6 | |
| ISKLHAIIDPNHEIE | 741 | P33981 | |
| SNLELHQQLHLRDKP | 271 | A6NK53 | |
| HQQLHLRDKPHVNVE | 276 | A6NK53 | |
| TNLIIHQKIHTGERP | 481 | Q5JVG2 | |
| DSKQLILEGQHHVIL | 1251 | Q9Y2L5 | |
| HIIHRDIKPDNILLD | 141 | Q9NY57 | |
| LIQHQRIHTGEKPFI | 301 | Q8N859 | |
| EELEKHVLTRHPQLS | 276 | Q2M1K9 | |
| HVLTRHPQLSEKADL | 281 | Q2M1K9 | |
| LHISSRDQNIPHKDL | 921 | Q9BXT5 | |
| PKLEQLVESHIQHSL | 316 | Q9BR11 | |
| RKLHNLPTQVSAIHI | 496 | Q6BDS2 | |
| KLVLEIIHRIPTNEH | 91 | Q9Y4A5 | |
| KPVAEILHESHAVRL | 541 | O95932 | |
| AILVQHLRIHTGEKP | 91 | Q96CX3 | |
| LQLTLHQRIHTGEKP | 426 | Q8TAF7 | |
| SQLSHIPEDKDHQVR | 491 | P49815 | |
| DTKQVPHTHEREINV | 446 | B1ANS9 | |
| AALIVHQRIHTGEKP | 571 | Q4V348 | |
| VSLLIQHLRIHTQEK | 376 | Q9NR11 | |
| ILSVERNITKPEHNH | 1286 | P82987 | |
| RNITKPEHNHLSVVV | 1291 | P82987 | |
| LHVDPHQRLTAKQVL | 656 | Q15418 | |
| QPAKERSILSVQHHI | 746 | Q8IZF0 | |
| HEPAVLHNLKVRFLE | 81 | Q9ULV0 | |
| KERHQLQLQLLEHET | 311 | P0CAP1 |